119 related articles for article (PubMed ID: 8603410)
1. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
Millauer B; Longhi MP; Plate KH; Shawver LK; Risau W; Ullrich A; Strawn LM
Cancer Res; 1996 Apr; 56(7):1615-20. PubMed ID: 8603410
[TBL] [Abstract][Full Text] [Related]
2. Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of disease.
Brown LF; Dvorak AM; Dvorak HF
Am Rev Respir Dis; 1989 Oct; 140(4):1104-7. PubMed ID: 2478057
[TBL] [Abstract][Full Text] [Related]
3. Association of Kinase-Insert-Domain-Containing Receptor Polymorphisms with Glioma Susceptibility in a Chinese Population: A Hospital-Based Case-Control Study.
Huang ZF; Zhu W; Wang C; Mo LD; Huang HL; Tong XG
Evid Based Complement Alternat Med; 2023; 2023():8808422. PubMed ID: 37114147
[TBL] [Abstract][Full Text] [Related]
4. Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling.
Chakraborty S; Ain R
J Biol Chem; 2017 Apr; 292(16):6600-6620. PubMed ID: 28235804
[TBL] [Abstract][Full Text] [Related]
5. Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.
Alldredge JK; Tewari KS
Oncologist; 2016 May; 21(5):576-85. PubMed ID: 27026677
[TBL] [Abstract][Full Text] [Related]
6. Correlation between VEGFR2 rs2071559 polymorphism and glioma risk among Chinese population.
Xu GZ; Liu Y; Zhang Y; Yu J; Diao B
Int J Clin Exp Med; 2015; 8(9):16724-8. PubMed ID: 26629211
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma.
Jary M; Vernerey D; Lecomte T; Dobi E; Ghiringhelli F; Monnien F; Godet Y; Kim S; Bouché O; Fratte S; Gonçalves A; Leger J; Queiroz L; Adotevi O; Bonnetain F; Borg C
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):603-12. PubMed ID: 25583947
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of VEGF: a novel mechanism to control angiogenesis by Withania somnifera's key metabolite Withaferin A.
Saha S; Islam MK; Shilpi JA; Hasan S
In Silico Pharmacol; 2013; 1():11. PubMed ID: 25505656
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of Bifidobacterium infantis-mediated sKDR prokaryotic expression system on angiogenesis and growth of Lewis lung cancer in mice.
Li ZJ; Zhu H; Ma BY; Zhao F; Mao SH; Liu TG; He JP; Deng LC; Yi C; Huang Y
BMC Cancer; 2012 Apr; 12():155. PubMed ID: 22536942
[TBL] [Abstract][Full Text] [Related]
10. Developmental antiangiogenic agents for the treatment of non-small cell lung cancer (NSCLC).
Blumenschein GR
Invest New Drugs; 2012 Aug; 30(4):1802-11. PubMed ID: 21987350
[TBL] [Abstract][Full Text] [Related]
11. Targeting angiogenesis in esophagogastric adenocarcinoma.
Okines AF; Reynolds AR; Cunningham D
Oncologist; 2011; 16(6):844-58. PubMed ID: 21632459
[TBL] [Abstract][Full Text] [Related]
12. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.
Francescone RA; Scully S; Faibish M; Taylor SL; Oh D; Moral L; Yan W; Bentley B; Shao R
J Biol Chem; 2011 Apr; 286(17):15332-43. PubMed ID: 21385870
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice.
Chinnasamy D; Yu Z; Theoret MR; Zhao Y; Shrimali RK; Morgan RA; Feldman SA; Restifo NP; Rosenberg SA
J Clin Invest; 2010 Nov; 120(11):3953-68. PubMed ID: 20978347
[TBL] [Abstract][Full Text] [Related]
14. Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumors.
Murakami H; Ueda Y; Shimoyama T; Yamamoto N; Yamada Y; Arioka H; Tamura T
Cancer Chemother Pharmacol; 2011 May; 67(5):1119-28. PubMed ID: 20676674
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.
Miyajima K; Takekoshi S; Itoh J; Kakimoto K; Miyakoshi T; Osamura RY
Acta Histochem Cytochem; 2010 May; 43(2):33-44. PubMed ID: 20514290
[TBL] [Abstract][Full Text] [Related]
16. A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia.
Chaiworapongsa T; Romero R; Tarca AL; Kusanovic JP; Gotsch F; Mittal P; Kim SK; Vaisbuch E; Mazaki-Tovi S; Erez O; Dong Z; Kim CJ; Yeo L; Hassan SS
Am J Obstet Gynecol; 2010 Jun; 202(6):550.e1-10. PubMed ID: 20510958
[TBL] [Abstract][Full Text] [Related]
17. Tumor angiogenesis: insights and innovations.
Nussenbaum F; Herman IM
J Oncol; 2010; 2010():132641. PubMed ID: 20445741
[TBL] [Abstract][Full Text] [Related]
18. Discovering collectively informative descriptors from high-throughput experiments.
Jeffries CD; Ward WO; Perkins DO; Wright FA
BMC Bioinformatics; 2009 Dec; 10():431. PubMed ID: 20021653
[TBL] [Abstract][Full Text] [Related]
19. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis.
Shao R; Hamel K; Petersen L; Cao QJ; Arenas RB; Bigelow C; Bentley B; Yan W
Oncogene; 2009 Dec; 28(50):4456-68. PubMed ID: 19767768
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of SU1498, an inhibitor of vascular endothelial growth factor receptor-2, in a transgenic murine model of retinoblastoma.
Cebulla CM; Jockovich ME; Boutrid H; Piña Y; Ruggeri M; Jiao S; Bhattacharya SK; Feuer WJ; Murray TG
Open Ophthalmol J; 2008 Apr; 2():62-7. PubMed ID: 19517030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
